The University of Chicago Header Logo

Connection

Ronald Cohen to Animals

This is a "connection" page, showing publications Ronald Cohen has written about Animals.
Connection Strength

0.513
  1. Laminin-a4 Negatively Regulates Adipocyte Beiging Through the Suppression of AMPKa in Male Mice. Endocrinology. 2022 10 11; 163(11).
    View in: PubMed
    Score: 0.048
  2. Laminin-a4 Is Upregulated in Both Human and Murine Models of Obesity. Front Endocrinol (Lausanne). 2021; 12:698621.
    View in: PubMed
    Score: 0.044
  3. Laminins in metabolic tissues. Metabolism. 2021 07; 120:154775.
    View in: PubMed
    Score: 0.043
  4. SMRT Regulates Metabolic Homeostasis and Adipose Tissue Macrophage Phenotypes in Tandem. Endocrinology. 2020 10 01; 161(10).
    View in: PubMed
    Score: 0.042
  5. The Absence of Laminin a4 in Male Mice Results in Enhanced Energy Expenditure and Increased Beige Subcutaneous Adipose Tissue. Endocrinology. 2018 01 01; 159(1):356-367.
    View in: PubMed
    Score: 0.035
  6. Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes. Mol Cell Endocrinol. 2015 May 15; 407:52-6.
    View in: PubMed
    Score: 0.028
  7. The silencing mediator of retinoid and thyroid hormone receptors (SMRT) regulates adipose tissue accumulation and adipocyte insulin sensitivity in vivo. J Biol Chem. 2010 Jun 11; 285(24):18485-95.
    View in: PubMed
    Score: 0.020
  8. Altering PPARgamma ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers. Obesity (Silver Spring). 2009 May; 17(5):965-72.
    View in: PubMed
    Score: 0.019
  9. SMRT recruitment by PPARgamma is mediated by specific residues located in its carboxy-terminal interacting domain. Mol Cell Endocrinol. 2007 Mar 15; 267(1-2):138-43.
    View in: PubMed
    Score: 0.016
  10. SMRT recruitment by PPARgamma is mediated by specific residues located in its carboxy-terminal interacting domain. Mol Cell Endocrinol. 2006 Oct 19; 259(1-2):43-9.
    View in: PubMed
    Score: 0.016
  11. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem. 2005 Apr 08; 280(14):13600-5.
    View in: PubMed
    Score: 0.014
  12. Atomic force microscopy characterization of white and beige adipocyte differentiation. In Vitro Cell Dev Biol Anim. 2024 Sep; 60(8):842-852.
    View in: PubMed
    Score: 0.013
  13. Nuclear corepressor SMRT acts as a strong regulator of both ß-oxidation and suppressor of fibrosis in the differentiation process of mouse skeletal muscle cells. PLoS One. 2022; 17(12):e0277830.
    View in: PubMed
    Score: 0.012
  14. Balanced control of thermogenesis by nuclear receptor corepressors in brown adipose tissue. Proc Natl Acad Sci U S A. 2022 08 16; 119(33):e2205276119.
    View in: PubMed
    Score: 0.012
  15. Investigation of insulin resistance through a multiorgan microfluidic organ-on-chip. Biomed Mater. 2022 01 18; 17(2).
    View in: PubMed
    Score: 0.011
  16. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol. 2001 Jul; 15(7):1049-61.
    View in: PubMed
    Score: 0.011
  17. Integrins and extracellular matrix proteins modulate adipocyte thermogenic capacity. Sci Rep. 2021 03 08; 11(1):5442.
    View in: PubMed
    Score: 0.011
  18. HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity. Genes Dev. 2020 07 01; 34(13-14):973-988.
    View in: PubMed
    Score: 0.010
  19. Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action. PLoS One. 2019; 14(8):e0220717.
    View in: PubMed
    Score: 0.010
  20. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol Endocrinol. 1998 Oct; 12(10):1567-81.
    View in: PubMed
    Score: 0.009
  21. Establishment and characterization of a primary murine adipose tissue-chip. Biotechnol Bioeng. 2018 08; 115(8):1979-1987.
    View in: PubMed
    Score: 0.009
  22. Protein kinase A induces UCP1 expression in specific adipose depots to increase energy expenditure and improve metabolic health. Am J Physiol Regul Integr Comp Physiol. 2016 07 01; 311(1):R79-88.
    View in: PubMed
    Score: 0.008
  23. HDAC3 Is a Master Regulator of mTEC Development. Cell Rep. 2016 Apr 19; 15(3):651-665.
    View in: PubMed
    Score: 0.008
  24. NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. Mol Cell Biol. 2015 Feb; 35(3):555-65.
    View in: PubMed
    Score: 0.007
  25. Laminin a4 deficient mice exhibit decreased capacity for adipose tissue expansion and weight gain. PLoS One. 2014; 9(10):e109854.
    View in: PubMed
    Score: 0.007
  26. Enhanced glycogen metabolism in adipose tissue decreases triglyceride mobilization. Am J Physiol Endocrinol Metab. 2010 Jul; 299(1):E117-25.
    View in: PubMed
    Score: 0.005
  27. Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma). J Biol Chem. 2010 Apr 30; 285(18):13517-24.
    View in: PubMed
    Score: 0.005
  28. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007 Oct 12; 282(41):29821-30.
    View in: PubMed
    Score: 0.004
  29. In vivo identification of a 107-base pair promoter element mediating neuron-specific expression of mouse gonadotropin-releasing hormone. Mol Endocrinol. 2007 Feb; 21(2):457-71.
    View in: PubMed
    Score: 0.004
  30. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem. 2006 Jan 06; 281(1):295-302.
    View in: PubMed
    Score: 0.004
  31. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest. 2005 Sep; 115(9):2517-23.
    View in: PubMed
    Score: 0.004
  32. A de novo mutation in an already mutant nucleotide of the thyroid hormone receptor beta gene perpetuates resistance to thyroid hormone. J Clin Endocrinol Metab. 2005 Mar; 90(3):1760-7.
    View in: PubMed
    Score: 0.004
  33. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. J Biol Chem. 2005 Feb 04; 280(5):3529-40.
    View in: PubMed
    Score: 0.003
  34. Thyroid hormone resistance in the heart: role of the thyroid hormone receptor beta isoform. Endocrinology. 2004 Apr; 145(4):1625-33.
    View in: PubMed
    Score: 0.003
  35. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J Clin Invest. 2003 Aug; 112(4):588-97.
    View in: PubMed
    Score: 0.003
  36. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol Endocrinol. 2003 Feb; 17(2):273-86.
    View in: PubMed
    Score: 0.003
  37. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest. 2002 Feb; 109(4):469-73.
    View in: PubMed
    Score: 0.003
  38. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci U S A. 2001 Mar 27; 98(7):3998-4003.
    View in: PubMed
    Score: 0.003
  39. T cell lines derived from the spinal cords of mice with experimental allergic encephalomyelitis are self reactive. J Immunol. 1986 Sep 15; 137(6):1850-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.